期刊文献+

Vaspin与内分泌相关疾病的关系

Relationship of vaspin and endocrine related diseases
原文传递
导出
摘要 内脏脂肪组织来源的丝氨酸蛋白酶抑制剂(vaspin)是新近发现的一种脂肪细胞因子,具有改善葡萄糖耐量,增加胰岛素敏感性的作用。研究发现,vaspin在脂肪组织、肝脏、皮肤、胰腺、下丘脑等器官均有表达,其表达受性别、年龄、饮食、运动、药物及激素等多因素影响。研究表明,vaspin在内分泌相关疾病的发生、发展中发挥了胰岛素增敏、激素分泌调节及抗炎等重要作用。 Visceral adipose tissue-derived serine protease inhibitor (vaspin), a newly identified adipocytokine, can improve glucose tolerance and insulin sensitivity. Expression of vaspin has been found in adipose tissue,liver, skin, pancreas, and hypothalamus, and can be influenced by multiple factors including gender, age, diet, excise, drugs, and hormone. Studies have demonstrated that vaspin plays an important role in insulin-sensitizing, regulating hormone secretion and anti-inflammatory of endocrine related diseases.
出处 《国际内分泌代谢杂志》 北大核心 2012年第1期41-43,共3页 International Journal of Endocrinology and Metabolism
关键词 VASPIN 脂肪因子 肥胖 糖尿病 非酒精性脂肪性肝病 Vaspin Adipocytokine Obesity Diabetes mellitus Nonalcoholic fatty liver disease
  • 相关文献

参考文献2

二级参考文献15

  • 1Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, et al. Mefformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008; 57: 1501-1507.
  • 2Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009; 160: 65-70.
  • 3Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 57: 372-377.
  • 4Kloting N, Berndt J, Kralisch S, Kovacs E Fasshauer M, Schon MR, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006; 339: 430-436.
  • 5Gonzalez-Ortiz M, Martinez-Abundis E. Comparison of several formulas to assess insulin action in the fasting state with the hyperglycemic-hyperinsulinemic clamp technique in healthy individuals. Rev Invest Clin 2003; 55:419-422.
  • 6Bao Y, Lu J, Wang C, Yang M, Li H, Zhang X, et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 2008; 201: 378-384.
  • 7World Health Organization: definition, diagnosis and classification of diabetes mellitus and its complication. WHO/NCD/NCS 1999: 31-33. (Accessed at http://whqlibdoc. who. int/hq/1999/WHO_NCD_NCS_99. 2.pdj-').
  • 8WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
  • 9Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008; 93: 247-251.
  • 10Alessi MC, Poggi M, Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 2007; 18: 240-245.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部